LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lixte Biotechnology Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Lixte Biotechnology Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$986K, a 3.21% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$4M, a 29.6% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.09M, a 19.4% increase from 2022.
  • Lixte Biotechnology Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$6.31M, a 6.18% increase from 2021.
  • Lixte Biotechnology Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.73M, a 106% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$4M -$986K +$32.7K +3.21% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$4.03M -$1.01M +$657K +39.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$4.69M -$971K +$396K +29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$5.09M -$1.03M +$599K +36.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$5.69M -$1.02M +$459K +31.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$6.15M -$1.67M -$122K -7.89% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$6.02M -$1.37M +$289K +17.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$6.31M -$1.63M +$398K +19.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$6.71M -$1.48M -$239K -19.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$6.47M -$1.55M +$187K +10.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$6.66M -$1.66M +$70.2K +4.07% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$6.73M -$2.03M -$1.12M -124% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$5.61M -$1.24M +$363K +22.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$5.97M -$1.73M -$1.36M -365% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$4.61M -$1.73M -$1.34M -351% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$3.26M -$907K -$585K -182% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$2.68M -$1.6M -$523K -48.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$2.16M -$373K +$237K +38.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$2.39M -$383K +$45.6K +10.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$2.44M -$322K +$26.5K +7.61% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$2.47M -$1.08M -$45.1K -4.36% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$2.42M -$610K -$239K -64.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$2.18M -$429K -$49.6K -13.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$2.13M -$349K +$84K +19.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$2.22M -$1.03M -$572K -124% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$1.65M -$371K -$78.6K -26.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 -$1.57M -$379K +$241K +38.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 -$1.81M -$433K +$83.6K +16.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-25
Q3 2017 -$1.89M -$462K +$185K +28.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$2.08M -$293K +$262K +47.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$2.34M -$621K -$204K -49% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$2.13M -$516K +$97.6K +15.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$2.23M -$647K +$133K +17% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$2.37M -$555K -$54.3K -10.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$2.31M -$417K +$541K +56.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$2.85M -$614K -$19.2K -3.23% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 -$2.83M -$780K -$278K -55.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$2.55M -$501K +$241K +32.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$2.8M -$958K -$29.1K -3.13% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$2.77M -$595K -$236K -65.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$2.53M -$501K -$188K -60.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$2.34M -$741K -$373K -101% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$1.97M -$929K -$595K -178% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$1.37M -$359K -$83.3K -30.2% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-27
Q3 2013 -$1.29M -$313K +$1.66M +84.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$2.96M -$369K +$365K +49.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$3.32M -$334K +$258K +43.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$3.58M -$276K +$394K +58.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-05-09
Q3 2012 -$3.97M -$1.98M -$1.28M -183% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$2.7M -$734K -$386K -111% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 -$2.31M -$592K -$241K -68.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$2.07M -$670K Oct 1, 2011 Dec 31, 2011 10-Q 2014-05-09
Q3 2011 -$699K -$321K -84.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$348K -$38.1K -12.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$351K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$378K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$310K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.